Cerus (CERS)

Company Profile

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.

Company profile

Ticker

CERS

Exchange

NASDAQ

Website

www.cerus.com

CEO

William Greenman

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • 3M • Teleflex • Resmed • West Pharmaceutical Services • Haemonetics • Hill-Rom ...

SEC CIK

0001020214

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Cerus Europe B.V. ...

IRS number

680262011

CERS stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

Prospectus update (post-effective amendment)

1 Mar 23

Automatic shelf registration (post-effective amendment)

1 Mar 23

8-K

Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022

28 Feb 23

8-K

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update

3 Nov 22

Cerus Corporation Announces Third Quarter Financial Results

3 Nov 22

CORRESP

Correspondence with SEC

24 Oct 22

Transcripts

View all

CERS

Earnings call transcript

2022 Q4

28 Feb 23

CERS

Earnings call transcript

2022 Q3

3 Nov 22

CERS

Earnings call transcript

2022 Q2

4 Aug 22

CERS

Earnings call transcript

2022 Q1

6 May 22

CERS

Earnings call transcript

2021 Q4

23 Feb 22

CERS

Earnings call transcript

2021 Q3

3 Nov 21

CERS

Earnings call transcript

2021 Q2

4 Aug 21

CERS

Earnings call transcript

2021 Q1

5 May 21

CERS

Earnings call transcript

2020 Q4

26 Feb 21

CERS

Earnings call transcript

2020 Q3

29 Oct 20

Latest ownership filings

View all

William Mariner Greenman

Financial summary

Financial statements Chart CERS financial data

Quarter (USD)	Dec 22	Sep 22	Jun 22	Mar 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	37.36 mm	37.36 mm	37.36 mm	37.36 mm	37.36 mm	37.36 mm
Cash burn (monthly)	(no burn)	1.14 mm	4.45 mm	3.53 mm	585.33 k	2.13 mm
Cash used (since last report)	n/a	3.07 mm	11.98 mm	9.50 mm	1.58 mm	5.75 mm
Cash remaining	n/a	34.29 mm	25.37 mm	27.86 mm	35.78 mm	31.61 mm
Runway (months of cash)	n/a	30.1	5.7	7.9	61.1	14.8

Beta Read what these cash burn values mean

Financial data from Cerus earnings reports.

Institutional ownership, Q4 2022

CERS institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	185	185	–
Opened positions	20	25	-20.0%
Closed positions	20	22	-9.1%
Increased positions	58	73	-20.5%
Reduced positions	75	46	+63.0%

13F shares	Current	Prev Q	Change
Total value	517.74 bn	508.37 mm	+101744.9%
Total shares	145.78 mm	141.41 mm	+3.1%
Total puts	196.50 k	677.90 k	-71.0%
Total calls	349.70 k	258.30 k	+35.4%
Total put/call ratio	0.6	2.6	-78.6%

Largest owners	Shares	Value	Change
Baker Bros. Advisors	16.07 mm	$58.65 bn	0.0%
ARK Investment Management	15.86 mm	$57.90 bn	-5.9%
BLK Blackrock	12.59 mm	$45.97 bn	+3.1%
Vanguard	10.90 mm	$39.79 bn	+4.3%
Primecap Management	8.85 mm	$32.30 bn	-4.5%
CMTDF Sumitomo Mitsui Trust	7.17 mm	$26.18 bn	-2.2%
Nikko Asset Management Americas	7.17 mm	$26.10 bn	-2.2%
Senvest Management	6.56 mm	$23.93 bn	+47.9%
Wasatch Advisors	4.86 mm	$17.76 bn	-8.6%
STT State Street	4.18 mm	$15.25 bn	NEW

Largest transactions	Shares	Bought/sold	Change
STT State Street	4.18 mm	+4.18 mm	NEW
Hood River Capital Management	4.12 mm	+2.43 mm	+143.6%
Senvest Management	6.56 mm	+2.12 mm	+47.9%
Kennedy Capital Management	945.23 k	-1.27 mm	-57.3%
ARK Investment Management	15.86 mm	-990.49 k	-5.9%
Millennium Management	685.16 k	-618.01 k	-47.4%
Polar Asset Management Partners	553.20 k	+553.20 k	NEW
D. E. Shaw & Co.	2.35 mm	-522.80 k	-18.2%
Wasatch Advisors	4.86 mm	-458.55 k	-8.6%
Vanguard	10.90 mm	+447.37 k	+4.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

CERS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
13 Mar 23	Benjamin Richard J	Common Stock	Sell	Dispose S	No	No	2.7793	10,000	27.79 k	347,439
13 Mar 23	Benjamin Richard J	Common Stock	Sell	Dispose S	No	Yes	2.8	5,747	16.09 k	357,439
13 Mar 23	Benjamin Richard J	Common Stock	Sell	Dispose S	No	Yes	2.8	9,606	26.90 k	346,519
13 Mar 23	Corash Laurence M	Common Stock	Sell	Dispose S	No	Yes	2.8	5,745	16.09 k	2,261,501
13 Mar 23	Corash Laurence M	Common Stock	Sell	Dispose S	No	Yes	2.8	9,597	26.87 k	2,250,579
13 Mar 23	Green Kevin Dennis	Common Stock	Sell	Dispose S	No	Yes	2.8	7,501	21.00 k	435,963
13 Mar 23	Green Kevin Dennis	Common Stock	Sell	Dispose S	No	Yes	2.8	9,662	27.05 k	421,797
13 Mar 23	Greenman William Mariner	Common Stock	Sell	Dispose S	No	No	2.8	22,732	63.65 k	2,658,346
13 Mar 23	Greenman William Mariner	Common Stock	Sell	Dispose S	No	No	2.8	37,748	105.69 k	2,616,411
13 Mar 23	Menard Chrystal	Common Stock	Sell	Dispose S	No	Yes	2.8	5,758	16.12 k	349,530